Propionic acidemia (PA) therapeutic: In an ongoing Phase 1/2 study designed to evaluate safety and pharmacology in trial participants with PA, Moderna's investigational therapeutic (mRNA-3927 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback